GR3005298T3 - - Google Patents

Info

Publication number
GR3005298T3
GR3005298T3 GR920401630T GR920401630T GR3005298T3 GR 3005298 T3 GR3005298 T3 GR 3005298T3 GR 920401630 T GR920401630 T GR 920401630T GR 920401630 T GR920401630 T GR 920401630T GR 3005298 T3 GR3005298 T3 GR 3005298T3
Authority
GR
Greece
Application number
GR920401630T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005298T3 publication Critical patent/GR3005298T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
GR920401630T 1986-08-01 1992-07-29 GR3005298T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868618847A GB8618847D0 (en) 1986-08-01 1986-08-01 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GR3005298T3 true GR3005298T3 (el) 1993-05-24

Family

ID=10602097

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401630T GR3005298T3 (el) 1986-08-01 1992-07-29

Country Status (22)

Country Link
US (1) US4996222A (el)
EP (1) EP0257823B1 (el)
JP (1) JPH0643304B2 (el)
KR (1) KR960012397B1 (el)
CN (1) CN1024497C (el)
AU (1) AU601206B2 (el)
CA (1) CA1287802C (el)
DE (1) DE3778795D1 (el)
DK (1) DK149988D0 (el)
EG (1) EG18388A (el)
ES (1) ES2037086T3 (el)
GB (1) GB8618847D0 (el)
GR (1) GR3005298T3 (el)
HU (1) HU205853B (el)
IE (1) IE60759B1 (el)
IL (1) IL83349A (el)
MY (1) MY100998A (el)
PH (1) PH23505A (el)
PT (1) PT85468B (el)
WO (1) WO1988000825A1 (el)
ZA (1) ZA875631B (el)
ZW (1) ZW13587A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
JPH0482832A (ja) * 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
NO941358L (no) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
WO1996003976A1 (en) * 1994-08-01 1996-02-15 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
GB2298365B (en) * 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
PL194696B1 (pl) * 1997-04-30 2007-06-29 Reckitt Benckiser Healthcare Kompozycja w stałej postaci dawkowania zawierająca alginiany
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
US6930119B2 (en) * 2002-07-17 2005-08-16 Reliant Pharmaceuticals, Inc. Liquid pharmaceutical composition
WO2004080343A2 (en) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Compositions and methods for use of alginate dural sealants
CN101052308A (zh) * 2004-11-02 2007-10-10 普拉克生化公司 使乳中蛋白质稳定并防止其凝固的方法
US20060094760A1 (en) * 2004-11-04 2006-05-04 Fawzy Abdel A Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) * 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
KR20120094473A (ko) * 2009-09-10 2012-08-24 바이알 - 포르텔라 앤드 씨에이 에스에이 에슬리카바제핀 아세테이트의 경구용 현탁액 제제
CN111481508A (zh) * 2016-10-19 2020-08-04 萨恩帕斯药物有限公司 针对引起离子通道病的药物的保护性组合物和方法
GB201918617D0 (en) * 2019-12-17 2020-01-29 Reckitt Benckiser Health Ltd Personal lubricant composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104868A (en) * 1980-01-24 1981-08-20 Fujimoto Seiyaku Kk Conversion between polymorphous crystals of cimetidine
HU185457B (en) * 1981-09-25 1985-02-28 Richter Gedeon Vegyeszet Process for preparating cimetidine-z
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
PT85468A (en) 1987-08-01
AU601206B2 (en) 1990-09-06
PT85468B (pt) 1990-06-29
EP0257823A1 (en) 1988-03-02
DE3778795D1 (de) 1992-06-11
AU7756487A (en) 1988-02-24
IE60759B1 (en) 1994-08-10
HUT46541A (en) 1988-11-28
WO1988000825A1 (en) 1988-02-11
IE872077L (en) 1988-02-01
MY100998A (en) 1991-06-29
ZW13587A1 (en) 1989-02-15
CN87105387A (zh) 1988-02-17
US4996222A (en) 1991-02-26
DK149988A (da) 1988-03-18
PH23505A (en) 1989-08-16
EP0257823B1 (en) 1992-05-06
KR960012397B1 (ko) 1996-09-20
JPH01500434A (ja) 1989-02-16
HU205853B (en) 1992-07-28
CA1287802C (en) 1991-08-20
IL83349A (en) 1992-03-29
CN1024497C (zh) 1994-05-18
ES2037086T3 (es) 1993-06-16
JPH0643304B2 (ja) 1994-06-08
EG18388A (en) 1992-10-30
ZA875631B (en) 1989-03-29
GB8618847D0 (en) 1986-09-10
KR880701551A (ko) 1988-11-03
DK149988D0 (da) 1988-03-18

Similar Documents

Publication Publication Date Title
DE3779351D1 (el)
DE8701482U1 (el)
DE3690695T1 (el)
GR3005298T3 (el)
DE3685878T (el)
DE3683300D1 (el)
DE3690728T1 (el)
IN171229B (el)
AU7354491A (el)
CH677995GA3 (el)
DE3690727T1 (el)
DE8706962U1 (el)
DE8625386U1 (el)
AU6562586A (el)
DE3690688T1 (el)
DE8621265U1 (el)
DE8624279U1 (el)
DE8626959U1 (el)
CU21934A3 (el)
DE8604095U1 (el)
DE8700176U1 (el)
AU5444986A (el)
DE8628397U1 (el)
AU5724586A (el)
BE905208A (el)